These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


305 related items for PubMed ID: 25597410

  • 1. Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1.
    Que T, Song Y, Liu Z, Zheng S, Long H, Li Z, Liu Y, Wang G, Liu Y, Zhou J, Zhang X, Fang W, Qi S.
    Oncogene; 2015 Sep 17; 34(38):4952-63. PubMed ID: 25597410
    [Abstract] [Full Text] [Related]

  • 2. Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion.
    Xia Z, Liu F, Zhang J, Liu L.
    PLoS One; 2015 Sep 17; 10(7):e0132399. PubMed ID: 26134825
    [Abstract] [Full Text] [Related]

  • 3. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H, Yu L, Liu J, Bian X, Shi C, Sun C, Zhou X, Wen Y, Hua D, Zhao S, Ren L, An T, Luo W, Wang Q, Yu S.
    Oncotarget; 2017 Mar 21; 8(12):19723-19737. PubMed ID: 28160566
    [Abstract] [Full Text] [Related]

  • 4. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
    Wang H, Yan X, Ji LY, Ji XT, Wang P, Guo SW, Li SZ.
    Technol Cancer Res Treat; 2017 Aug 21; 16(4):497-511. PubMed ID: 26868851
    [Abstract] [Full Text] [Related]

  • 5. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
    Dong H, Cao W, Xue J.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1074-1081. PubMed ID: 30553445
    [Abstract] [Full Text] [Related]

  • 6. miR-142 inhibits the migration and invasion of glioma by targeting Rac1.
    Qin W, Rong X, Dong J, Yu C, Yang J.
    Oncol Rep; 2017 Sep 22; 38(3):1543-1550. PubMed ID: 28714015
    [Abstract] [Full Text] [Related]

  • 7. MiR-410 regulates MET to influence the proliferation and invasion of glioma.
    Chen L, Zhang J, Feng Y, Li R, Sun X, Du W, Piao X, Wang H, Yang D, Sun Y, Li X, Jiang T, Kang C, Li Y, Jiang C.
    Int J Biochem Cell Biol; 2012 Nov 22; 44(11):1711-7. PubMed ID: 22750473
    [Abstract] [Full Text] [Related]

  • 8. miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis.
    Chai Z, Fan H, Li Y, Song L, Jin X, Yu J, Li Y, Ma C, Zhou R.
    Oncol Rep; 2017 Nov 22; 38(5):2717-2726. PubMed ID: 29048686
    [Abstract] [Full Text] [Related]

  • 9. miR-5188 augments glioma growth, migration and invasion through an SP1-modulated FOXO1-PI3K/AKT-c-JUN-positive feedback circuit.
    Yi R, Yang S, Lin X, Zhong L, Liao Y, Hu Z, Huang T, Long H, Lin J, Wu Z, Xie C, Ding S, Luo J, Luo Q, Song Y.
    J Cell Mol Med; 2020 Oct 22; 24(20):11800-11813. PubMed ID: 32902145
    [Abstract] [Full Text] [Related]

  • 10. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.
    Li B, Wang Y, Li S, He H, Sun F, Wang C, Lu Y, Wang X, Tao B.
    Int J Clin Exp Pathol; 2015 Oct 22; 8(6):7016-21. PubMed ID: 26261592
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-149 inhibits proliferation and invasion of glioma cells via blockade of AKT1 signaling.
    Pan SJ, Zhan SK, Pei BG, Sun QF, Bian LG, Sun BM.
    Int J Immunopathol Pharmacol; 2012 Oct 22; 25(4):871-81. PubMed ID: 23298478
    [Abstract] [Full Text] [Related]

  • 12. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.
    Chen X, Hao B, Han G, Liu Y, Dai D, Li Y, Wu X, Zhou X, Yue Z, Wang L, Cao Y, Liu J.
    J Cell Biochem; 2015 Feb 22; 116(2):225-32. PubMed ID: 25160587
    [Abstract] [Full Text] [Related]

  • 13. MiRNA-451 plays a role as tumor suppressor in human glioma cells.
    Nan Y, Han L, Zhang A, Wang G, Jia Z, Yang Y, Yue X, Pu P, Zhong Y, Kang C.
    Brain Res; 2010 Nov 04; 1359():14-21. PubMed ID: 20816946
    [Abstract] [Full Text] [Related]

  • 14. miR-548b inhibits the proliferation and invasion of malignant gliomas by targeting metastasis tumor-associated protein-2.
    Pan Y, Liang W, Zhao X, Liu L, Qing Y, Li Y.
    Neuroreport; 2016 Dec 07; 27(17):1266-1273. PubMed ID: 27682888
    [Abstract] [Full Text] [Related]

  • 15. MiR-125a-3p regulates glioma apoptosis and invasion by regulating Nrg1.
    Yin F, Zhang JN, Wang SW, Zhou CH, Zhao MM, Fan WH, Fan M, Liu S.
    PLoS One; 2015 Dec 07; 10(1):e0116759. PubMed ID: 25560389
    [Abstract] [Full Text] [Related]

  • 16. MiR-16-1 plays a role in reducing migration and invasion of glioma cells.
    Li X, Ling N, Bai Y, Dong W, Hui GZ, Liu D, Zhao J, Hu J.
    Anat Rec (Hoboken); 2013 Mar 07; 296(3):427-32. PubMed ID: 23175429
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
    Xue H, Guo X, Han X, Yan S, Zhang J, Xu S, Li T, Guo X, Zhang P, Gao X, Liu Q, Li G.
    Oncotarget; 2016 Jan 26; 7(4):4785-805. PubMed ID: 26715733
    [Abstract] [Full Text] [Related]

  • 18. miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.
    Jiang L, Wang C, Lei F, Zhang L, Zhang X, Liu A, Wu G, Zhu J, Song L.
    Oncotarget; 2015 Apr 10; 6(10):8286-99. PubMed ID: 25823655
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of MicroRNA-216a Suppresses Proliferation, Migration, and Invasion of Glioma Cells by Targeting Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5.
    Zhang J, Xu K, Shi L, Zhang L, Zhao Z, Xu H, Liang F, Li H, Zhao Y, Xu X, Tian Y.
    Oncol Res; 2017 Sep 21; 25(8):1317-1327. PubMed ID: 28256193
    [Abstract] [Full Text] [Related]

  • 20. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
    Liu J, Xu J, Li H, Sun C, Yu L, Li Y, Shi C, Zhou X, Bian X, Ping Y, Wen Y, Zhao S, Xu H, Ren L, An T, Wang Q, Yu S.
    Oncotarget; 2015 Oct 06; 6(30):29129-42. PubMed ID: 26320176
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.